European Blood Pressure Intensive Control After Stroke
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Stroke is the third most common cause of death worldwide and the leading cause of disability.
High blood pressure is an important risk factor for stroke. Lowering a person's blood
pressure reduces the risk of future stroke or heart attack. However, the optimal target blood
pressure after a person suffers a stroke is not known. This is a study designed to establish
the feasibility of a larger clinical trial, the aim of which will be to find out if greater
blood pressure lowering is safe and effective for patients who suffer a stroke.
Phase:
Phase 2
Details
Lead Sponsor:
University College Dublin
Collaborators:
Attikon Hospital Cork University Hospital Hospital Universitario La Paz HRB Stroke Trials Network Ireland Mater Misericordiae University Hospital National University of Ireland, Galway, Ireland Newcastle University St Vincent's University Hospital, Ireland Tallaght University Hospital Universitaire Ziekenhuizen Leuven University Hospital Waterford University of Calgary University of Limerick University of Oslo